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Purpose: To investigate the role of T-cell-mediated immune response in a monophasic experimental autoimmune uveitis
(EAU).
Methods: A monophasic EAU was induced in Lewis rats by immunization with interphotoreceptor retinoid-binding
protein  peptide.  Optimized  quantitative  real-time  RT–PCR  was  used  for  consecutive  measurement  of  the  relative
expression  of  Th17-associated  molecules,  including  interleukin  6  (IL-6),  transforming  growth  factor-β  (TGF-β),
interleukin 23p19 (IL-23p19), interleukin 23p40 (IL-23p40), CD4, CD8, major histocompatibility complex I (MHC I),
major histocompatibility complex II (MHC II), interleukin 17 (IL-17), interleukin 17F (IL-17F), interleukin 17 receptor
A (IL-17RA), retinoic acid-related orphan receptor γt (RORγt) and Chemokine receptor 6 (CCR6), in addition to Treg-
related forkhead box P3 (Foxp3), C-X-C chemokine receptor type 5 (CXCR5), and cluster of differentiation 25 (CD25)
at the initiation, effector, and resolution phases of EAU and compared with those at 14 days post-immunization of control
animals. Immunohistochemisty was used to examine IL-17 expression in retinas. Glial fibrillary acidic protein retinal
astrocytes, Neuronal class III β-Tubulin(Tuj1+)retinal ganglion cells, and infiltrating CD11b+ microglia were analyzed by
fluorescent microscopy in a kinetic manner.
Results: Our results indicated well organized T-cell activity, measured by relative expression of multiple T-cell-related
factors at the mRNA level, synchronized with the initiation of autoimmune inflammation, and thereafter resolution of the
monophasic EAU. Immune balance was achieved several times through coordinated expression of Th17- and Treg-related
factors. The expression pattern of these factors and results from immunochemistry with an IL-17 antibody indicated that
there may be intensive crosstalk between infiltrating immune cells and the resident neural cells, which were significantly
activated during the course of disease.
Conclusions: T-cell-mediated immune response played a positive role in resolution of the monophasic EAU.
Experimental autoimmune uveitis (EAU) is an organ-
specific, T-cell-mediated, autoimmune disease that targets the
neural retina and related tissues [1]. The pathology of EAU
resembles  human  uveitic  diseases  of  a  recognized
autoimmune  nature  in  which  patients  present  with
immunological  responses  to  retinal  antigens  [1,2].
Immunization with the immunodominant 1177–1191 peptide
(R16) of interphotoreceptor retinoid-binding protein (IRBP)
results in a monophasic EAU in susceptible Lewis rats in
which intraocular inflammation appears around day 8 after
immunization,  lasts  for  approximately  2  weeks,  and  then
spontaneously resolves [3]. In contrast, recurrent uveitis that
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can  be  induced  by  adoptive  transfer  of  antigen-specific
lymphocytes is characterized by recurring attacks of CD4+ T
cells targeting intraocular structures, particularly the retina.
As the retina assembles as part of the central nervous system
(CNS), affected areas with destructive architecture are unable
to reorganize and therefore remain functionally compromised
[1,3]. Over the years, efforts have focused on understanding
the  mechanisms  involved  in  the  natural  resolution  of
monophasic  uveitis  and  identifying  optimal  therapeutic
strategies for human recurrent or chronic uveitis.
The nature of monophasic EAU to spontaneously resolve
after  tremendous  ocular  inflammation  suggests  that  the
involved  T-cell  autoimmunity  could  be  a  beneficial
physiologic response evoked to defend, repair, and maintain.
At the effector stage of EAU or other autoimmune diseases,
high levels of interferon-γ (IFN-γ) or interleukin 17 (IL-17),
produced  by  T-helper  type  1  (Th1)  or  Th17  cells,  were
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1493believed  to  be  critically  pathogenic  [2,4,5].  However,
evidence indicates that IFN-γ affects glutamate uptake by
resident astrocytes in mice subjected to optic nerve injury
[6,7]. The dual nature of IL-17A to be either pathogenic or
protective has been reported, and its specific function may
depend on the stage of different autoimmune diseases [5,8,
9]. On the other hand, during autoimmune inflammation in the
CNS,  astrocytes  and  microglia  that  encounter  adaptive
immunity could be activated, become capable of presenting
antigens and engaging in a dialog with T cells, and perform
protective activities against local threats [10]. A recent report
indicated that astrocytes play an important physiologic role in
CNS homeostasis and could serve as a target of Th17 and
IL-17 [11]. Other relevant studies have suggested that neuron-
[12] or astrocyte- [13] induced regulatory T cells (Treg) may
represent an important mechanism for self-limiting excessive
inflammation in the brain. Further evidence has shown that
retinal ganglion cells (RGCs) exposed to a glutamate insult or
suffering the secondary consequences of an optic nerve crush
injury could be protected by vaccination with IRBP in both
susceptible Lewis rats and Fisher rats resistant to EAU [14].
Heterogenity and plasticity of effector/regulatory T-cell
subsets and function of a given T-cell lineage involved in
autoimmune  inflammation  are  currently  being  debated.
Immunosuppressive Treg and pro-inflammatory Th17 cells
functionally  antagonize  each  other.  However,  as  their
differentiation programs are reciprocally inter-related, recent
data  has  revealed  that  they  may  support  each  other  in
differentiation and expansion. For example, in the presence of
interleukin 6 (IL-6) or interleukin 1β (IL-1β), transforming
growth factor-β (TGF-β) produced by Treg may promote the
generation  of  Th17  cells  from  naïve  CD4  cells  [15,16].
Plasticity  of  Treg  was  recently  demonstrated.  Treg  are
reported  to  lose  their  suppressive  function  and  be
reprogrammed to the Th17 phenotype in the presence of TGF-
β and IL-6 [16-18]. Significant numbers of CD4 T cells co-
expressing forkhead box P3 (Foxp3) and retinoic acid-related
orphan receptor γt (RORγt) transcriptional factors have been
found in human peripheral tissues; these cells produced IL-17
and powerfully inhibited the proliferation of CD4 responder
cells [19]. Thus, the ability to suppress responder cells and at
the same time generate IL-17 may render these cells with a
twin  role  in  antimicrobial  defense,  while  controlling
autoimmunity  and  inflammation.  These  and  other  reports
indicate that the interplay and interconnection between Th17
and Treg are much more complex than generally appreciated
[20,21].
With the use of large-scale analysis approaches, it should
be possible to extract more detailed information out of these
complex  biologic  systems  and  understand  the  complex
biology  and  mechanisms  by  which  inappropriate  T-cell
activity  results  in  chronic  pathology.  In  this  study  by
measuring the consecutive expression of multiple Th17- and
Treg-related  molecules  locally  at  the  mRNA  level  and
systematically in the monophasic EAU with Lewis rats, we
showed how kinetics of effector/regulatory T-cell activity
synchronized  the  initiation  and  resolution  of  autoimmune
inflammation in vivo. In addition, the expression pattern of
these inter-related molecules and other related data support
intensive crosstalk between the infiltrating immune cells and
resident neural cells in the course of disease.
METHODS
Animals:  Female  Lewis  rats  (160–180  g,  5–6  weeks)  of
specified pathogen-free grade were purchased from Peking
Vital River Laboratory Animal Ltd. (Beijing, China). All rats
were fed and maintained in specified pathogen-free conditions
according to the guidelines of Care and Use of Laboratory
Animals published by the China National Institute of Health.
All experimental procedures adhered to the Association for
Research in Vision and Ophthalmology Statement for the use
of animals in ophthalmic and vision research.
Induction of experimental autoimmune uveitis: Peptide R16
of  bovine  IRBP  (residues  1177–1191,  sequence
ADGSSWEGVGVVPDV) was synthesized by solid-phase
techniques  and  puriﬁed  by  HPLC  (Chinese  Peptide  Co.,
Hangzhou,  China).  The  peptide  was  prepared  by
emulsification  of  50  µg  IRBP  R16  peptide  in  Freund's
Complete Adjuvant CFA (Sigma-Aldrich, St. Louis, MO)
containing 2.5 mg/ml of mycobacterium tuberculosis H37Ra
in a total volume of 0.1 ml. Rats were divided into two groups;
the EAU group received an injection of 0.1 ml peptide antigen
in each of the footpads and the CFA control received an equal
volume of injection at the same locations with PBS emulsified
with  CFA.  Concurrently,  both  groups  of  animals  were
intraperitoneally injected with 1 μg of pertussis toxin (Sigma-
Aldrich) [3] in a volume of 0.1 ml for more accurate onset of
EAU. Animals were monitored daily, and specified tissues
were  collected  for  further  studies.  Three  batches  of
immunization, each including 35 Lewis rats, were used for
EAU induction, while the respective control of 15 animals was
also prepared.
Clinical and histopathological assessment: All animals were
monitored  daily.  Clinical  signs  were  scored  by  slit-lamp
biomicroscopy according to the following criteria [3]: 0, the
eye is translucent and reflects light; 0.5, dilated blood vessels
in the iris; 1.0, engorged blood vessels in the iris, abnormal
pupil contraction; 2.0, hazy anterior chamber, decreased red
reflex; 3.0, moderately opaque anterior chamber but pupil still
visible, dull red reflex; 4.0, opaque anterior chamber and
obscured pupil, red reflex absent, proptosis. Clinical scores
were analyzed using a nonparametric Mann–Whitney U test;
p<0.05 was regarded as statistically significant.
The degree of eye inflammation was also confirmed by
histopathological  analysis.  Briefly,  the  entire  eye  ball  of
euthanized animals was freshly dissected and fixed in 4%
formaldehyde for 24 h, before the corneas were cut and lens
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1494carefully  removed.  Fixed  eyes  were  routinely  embedded
in  paraffin  blocks,  and  2-μm  sections  were  stained  with
hematoxylin  and  eosin  (Zhongshan  Goldenbridge,
Guangzhou, China). The presence of disease was evaluated
blindly by examining six sections cut through the pupillary–
optic nerve plane at different levels for each eye. Severity of
EAU was scored on a scale of 0 (no disease) to 4 (maximum
disease) [3]: 0, no disease, normal retinal architecture; 0.5,
mild  inflammatory  cell  infiltration  of  the  retina  with  or
without photoreceptor damage; 1.0, mild inflammation and/
or photoreceptor outer segment damage; 2.0, mild to moderate
inflammation and/or lesion extending to the outer nuclear
layer; 3.0, moderate to marked inflammation and/or lesion
extending to the inner nuclear layer; 4.0, severe inflammation
and/or full-thickness retinal damage.
Quantitative real-time RT–PCR: To avoid variations among
different batches of immunizations and individual rats in the
same batch, two rats of the same immunization batch at each
selected time point (with close clinical scores on their eyes)
were used for quantitative real-time RT–PCR analysis. Tissue
samples from two rats of the CFA group at 14 days post
immunization (dpi) were used as controls. Data from the third
batch of immunization are shown in Table 1, Table 2, and
Table 3. Consistent results were obtained among batches of
immunization.  Briefly,  freshly  isolated  retinas,  draining
lymph nodes, and spleens from selected EAU and control
animals were rapidly embedded in RNAlater (Sigma-Aldrich)
and stored at –20 °C. Total RNA was extracted from these
tissues with Trizol reagent (Invitrogen, Shanghai, China), and
1 µg of RNA was reverse transcribed using High-Capacity
cDNA  Reverse  Transcription  kits  (Applied  Biosystems,
Foster City, CA). The cDNA solution was mixed into one bulk
solution for each kind of tissue from selected EAU or control
rats at each time point, and the relative expression of Th17-
or  Treg-associated  molecules  at  the  mRNA  level  was
analyzed.
The Vandesompele et al. [22] method was adopted for the
selection of housekeeping genes as internal genomic controls.
Five housekeeping genes, including heat shock protein 90kDa
alpha class B member 1 (Hsp90ab1), ribosomal RNA 18s
(18S),  lactate  dehydrogenase  A  (Ldha),  arginine-glycine-
aspartic acid (RGD), and ribosomal protein 13a (Rp113a)
were tested on selected tissues (retinas, lymph nodes, and
spleen) from control rats at 14 dpi for relevant gene stability.
Four genes (18s, Ldha, Hsp90ab1, Rp113a) were used for
normalization of the spleen and lymphoid node samples and
three (Ldha, RGD, Rp113a) were used for the retina samples.
Sequences of specific primers (Sangon Ltd., Shanghai, China)
for     the          examined          molecules                 e r a              available          in
Appendix 1.
The real-time PCR reaction was set up in a 15-µl volume
using 2× FastStart Universal SYBR Green Master Mix (Roche
TABLE 1. RELATIVE EXPRESSION (FOLD CHANGE OF CONTROL) OF TH17-ASSOCIATED AND TREG-RELATED FACTORS AT THE MRNA
LEVEL FROM DRAINING LYMPH NODES DURING MONOPHASIC EAU WITH LEWIS RATS.
Genes                                                  Con 7 d 14 d 21 d 28 d 35 d
Th17-related
IL-6 1.00 7.67 1.76 2.73 1.57 1.25
TGF-β 1.00 0.61 0.85 1.41 1.21 1.31
IL-23p19 1.00 0.63 1.00 0.65 0.80 0.81
IL-23 (−12)p40 1.00 0.26 0.82 0.88 1.16 1.28
IL-17 1.00 42.63 20.22 1.51 3.21 1.94
IL-17F 1.00 15.77 2.42 0.98 0.91 0.84
IL-17R 1.00 0.28 0.30 0.02 0.09 0.08
CD4 1.00 0.63 0.88 1.23 1.05 1.10
MHC II 1.00 1.74 2.48 0.88 1.25 1.09
CD8 1.00 0.91 1.04 1.22 1.10 1.58
MHC I 1.00 1.06 1.35 0.67 0.84 0.90
RORγt 1.00 1.76 1.64 1.74 1.67 1.88
CCR6 1.00 0.74 0.85 1.39 1.09 1.35
Treg-related
Foxp3 1.00 0.44 0.68 0.77 0.81 0.93
CXCR5 1.00 1.97 2.72 0.92 1.12 1.22
CD25 1.00 0.72 0.81 1.12 0.89 1.25
        Notes: con*, tissue counterparts were obtained from control rats, relative expression of the gene of interest was measured by
        the same method with the EAU rats and set as 1.00, respectively. Genes showing at least a twofold change were recognized as
        being significantly altered. Significantly increased expression was labeled in bold and decreased in italic.
Molecular Vision 2011; 17:1493-1507 <http://www.molvis.org/molvis/v17/a168> © 2011 Molecular Vision
1495Ltd., Basel, Switzerland) in which 0.375 μM of each primer
and 0.5 μl cDNA were used. The PCR reaction was performed
using an ABI STEPONE real-time PCR System (Applied
Biosystems) with an initial denaturation of 95 °C for 10 min,
followed by 40 cycles of 95 °C for 15 s and 60 °C for 1 min.
Relative gene expression levels were quantified using the
comparative ǻ CT method. This method normalized CT values
of the detected gene to the average of that of the housekeeping
genes and calculated the relative expression values as fold
changes of the control, which was set at 1.00. Melting curve
analyses and electrophoresis was    performed  to verify the
specificity  of  the  PCR  products.  Each  experiment  was
performed in duplicate and repeated two to three times, and
the  standard  deviation  among  repeated  experiments  were
stringently less than 2% when analyzed by the Student t test
(data  not  shown).  Tissue  selection  and  preparation  for
optimized quantitative real-time RT–PCR analysis is shown
in Figure 1B.
Immunohistochemistry: Paraffin blocks of the eye from both
EAU and control animals were prepared as described above.
Antigen retrieval was performed by microwave-heating and
nonspecific protein-binding sites were blocked by 4% normal
goat serum plus 1% bovine serum albumin (BSA) in PBS for
30 min. The 2-um sections were incubated with an antirat
IL-17  rabbit  polyclonal  antibody  (1:100;  Santa  Cruz
Biotechnology Inc., Santa Cruz, CA). Parallel nonimmune
rabbit  IgG  was  used  as  a  negative  control.  Biotinylated
secondary  antibody,  avidin:biotinylated  enzyme  complex,
and 3,3′-diaminobenzidine substrate were used as detecting
reagents  (Zhongshan  Goldenbridge  Biotechnology).  The
slides  were  counterstained  with  hematoxylin  and  finally
mounted with mounting medium and analyzed.
Direct and indirect immunofluorescent microcopy: The eye
cups  were  obtained  from  freshly  dissected  eye  balls  by
carefully cutting off the corneas and removing the vitreous
and  lens  on  ice.  Optimal  Cutting  Temperature™  O.C.T
embedding medium (Richard-Allan Scientific, Kalamazoo,
MI) was immediately applied to fill the eye cup, which was
then snap frozen in liquid nitrogen and stored at −80 °C until
use. Ten-micrometer sections at the coronal plane of the eye
cup  were  cut  by  a  cryostat  (Microm  HM525,  Walldorf,
Germany).
For  sections  subjected  to  indirect  immunofluorescent
microscopy, the samples were fixed in 4% paraformaldehye
and then blocked in 4% goat serum in PBS containing 1%
BSA and 0.6% Triton X-100. Primary antibody incubation
was performed in 1% goat serum and 0.1% BSA in PBS at
4  °C  overnight.  These  antibodies  included  antirat  Tuj-1
(neuron-specific  class  III  beta-tubulin)  mouse  monoclonal
antibody (1:250; Covance Inc., Princeton, NJ) and antirat
CD11b  mouse  monoclonal  antibody  (1:200;  Abcam  Inc.,
Cambridge,  MA).  Sections  were  incubated  with  FITC-
conjugated  or  Texas  Red-conjugated  goat  antimouse
secondary  antibody  (1:200;  Becton  Dickinson,  Franklin
TABLE 2. RELATIVE EXPRESSION (FOLD CHANGE OF CONTROL) OF TH17-ASSOCIATED AND TREG-RELATED FACTORS AT THE MRNA
LEVEL FROM THE SPLEEN DURING MONOPHASIC EAU WITH LEWIS RATS.
Genes                                               Con 7 d 14 d 21 d 28 d 35 d
Th17 related
IL-6 1.00 0.69 0.90 0.78 1.06 1.09
TGF-β 1.00 0.90 0.92 0.67 0.89 0.91
IL-23p19 1.00 0.97 1.11 0.90 1.27 1.24
IL-23 (−12) p40 1.00 0.60 0.76 0.85 0.75 0.86
IL-17 ND$ ND$ ND$ ND$ ND$ ND$
IL-17F ND$ ND$ ND$ ND$ ND$ ND$
IL-17R 1.00 1.24 0.97 0.90 0.82 1.10
CD4 1.00 0.88 0.99 0.87 1.01 0.91
MHC II 1.00 0.79 0.74 0.72 0.84 0.73
CD8 1.00 1.54 0.56 0.53 0.71 0.65
MHC I 1.00 0.91 0.81 0.84 0.99 0.91
RORγt 1.00 1.20 1.83 1.07 1.15 1.20
CCR6 1.00 0.63 0.71 0.68 0.85 0.80
Treg-related
Foxp3 1.00 0.90 0.82 0.70 0.87 0.82
CXCR5 1.00 1.04 0.99 0.90 0.94 1.17
CD25 1.00 0.95 0.97 0.80 0.89 0.81
        Notes: con*, tissue counterparts were obtained from control Lewis rats, relative expression of the gene of interest was measured
         by the same method with the EAU rats and set as 1.00, respectively. ND$, the expression was too low to be detected. Genes
         showing at least a twofold change were recognized as being significantly altered.
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BSA for 1 h. The samples were then incubated with 2 μg/ml
2-(4-amidinophenyl) −6-indolecarbamidine dihydrochloride
(DAPI; Roche, Basel, Switzerland) for 10 min and the slides
were  mounted.  For  sections  subjected  to  direct
immunofluorescence,  FITC-conjugated  antibody  against
GFAP (1:30; Biosynthesis Biotechnology Co. Ltd., Peking,
China) was applied, and DAPI was used to counterstain the
cell  nucleus.  Images  were  taken  using  a  fluorescence
microscope (Nikon 80i; Nikon, Tokyo, Japan) with a cold
CCD camera (Nikon DS-Ri1; Nikon), which was equipped
with  NIS-Elements  AR  3.0  software  (Nikon).  Positive
staining was evaluated and analyzed blindly by a medical
pathologist.
Statistical analysis: Statistical evaluations of EAU scores and
repeated real-time PCR data obtained from the same sample
were  performed  by  the  Student  t  test.  Standard  Pearson
correlation analysis on the real-time PCR data was performed
to indicate significant correlation between the time series data
of any of the tested T-cell-related factors and that of IL-17 in
retina within each of the three repeated experiments (Figure
1B).  Two-tailed  p  values  were  calculated.  The  level  of
significance was set to p<0.05 for both the Student t test and
Pearson correlation analysis. The Pearson correlation r value
was also calculated and interpreted as follows: 0.0 to 0.2, very
weak  to  negligible  correlation;  0.2  to  0.4,  weak,  low
correlation; 0.4 to 0.7, moderate correlation; 0.7 to 0.9, strong,
high correlation; 0.9 to 1.0, very strong correlation.
RESULTS
Evaluation  of  the  monophasic  EAU,  real-time  RT–PCR
design, and data validation: Each eye of both EAU and CFA
TABLE 3. RELATIVE EXPRESSIONS OF TH17- AND TREG- RELATED FACTORS AT THE MRNA LEVEL FROM RETINA DURING MONOPHASIC EAU WITH LEWIS RATS
AND STANDARD PEARSON CORRELATION ANALYSIS.
Genes
Relative expression as fold change Correlation with p
  con* 7 d 14 d 21 d 28 d 35 d IL-17 (r) (2-tailed)
Initiating factors
IL-6 1.00 1.62 33.01 3.30 2.86 6.92 0.882* 0.020
TGF-β 1.00 1.74 12.47 4.44 4.10 5.53 0.907* 0.013
Expansion factors
IL-23p19 1.00 1.34 1.10 1.15 0.85 1.80 −0.035 0.947
IL-23 (−12) p40 1.00 0.35 278.20 18.27 42.71 296.45 0.954** 0.003
Signature cytokines and receptor
IL-17 1.00 0.10 1573.6 15.05 49.24 80.54 — —
IL-17F 1.00 0.99 32.22 0.89 1.49 1.47 0.741 0.092
IL-17R 1.00 1.85 19.63 4.07 5.25 3.49 0.874* 0.023
Antigen presentation-associated factors
CD4 1.00 0.73 36.13 NA# 8.47 4.05 0.959** 0.010
MHC II 1.00 7.31 5202.54 76.47 624.55 993.70 0.906* 0.013
CD8 1.00 0.22 9.58 NA# 0.83 1.07 0.869 0.056
MHC I 1.00 0.95 8.63 0.66 1.60 3.46 0.790 0.061
Lineage markers
RORγt 1.00 1.10 6.02 0.70 0.92 3.09 0.679 0.138
CCR6 1.00 1.41 62.47 3.05 29.89 22.65 0.911* 0.012
Treg-related
Foxp3 1.00 0.86 10.59 0.84 1.59 4.63 0.839* 0.037
CXCR5 1.00 1.18 8.08 1.54 2.58 3.51 0.948* 0.014
CD25 1.00 1.15 146.02 NA# 18.72 5.14 0.915* 0.029
        Notes: The time series data are representative for experiments of three batches of immunization for inducing EAU model in
        Lewis rats as shown in Figure 1. con*, retina were obtained from CFA control rats at 14 dpi, the relative expression of each
        gene examined was set as 1.00, respectively; NA#, the data were not available. Genes showing at least a twofold change were
        recognized as being significantly altered. Significantly increased expression was labeled in bold and decreased in italic. Standard
        Pearson analysis was performed between the time series expressions of one of the examined molecules and that of IL-17.
        *Correlation is significant at the 0.05 level; **Correlation is significant at the 0.01 level (2-tailed).
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1497control animals were observed daily after immunization until
35 dpi, and clinical scores were recorded (Figure 1A). Mild
clinical signs, such as dilated or engorged blood vessels in the
iris, were observed at 8–9 dpi, and the most severe intraocular
inflammation was detected at 14 dpi, as evidenced by an
opaque anterior chamber and obscured pupil. At 21 dpi, the
ocular inflammation was greatly resolved, with only minor
clinical signs, and no inflammatory signs were detected at 28
or 35 dpi. No indication of clinical EAU was observed in any
of the CFA controls. All of these demonstrate an acute and
monophasic disease course. For further detailed analysis, the
course of EAU was separated into three phases, including an
initiation phase from the day of immunization until 7 dpi; an
effector  phase  from  7  to  21  dpi,  in  which  the  peak
inflammation was obtained at 14 dpi; and a resolution phase
beginning at 21 dpi (Figure 1A). Moreover, the results of
clinical observation on each stage of disease were further
confirmed by H&E histological analysis (data not shown) and
Figure  1.  Clinical  score  of  the
monophasic EAU and methodology of
real-time  PCR  analysis.  A:  Clinical
scores of the monophasic experimental
autoimmune  uveitis  (EAU).  Disease
severity was observed daily by slit-lamp
microscopy and graded as described in
the  Methods  section.  Based  on  the
clinical course, monophasic EAU was
divided into three stages: an initiation
phase from the day of immunization to
7 dpi; an effector phase beginning from
7 to 21 dpi, with the peak inflammation
obtained  at  14  dpi;  and  a  phase  of
resolution starting from 21 dpi. Data are
represented  as  the  mean±standard
deviation. B: Schematic tissue selection
and  preparation  for  optimized
quantitative real-time RT–PCR analysis
was shown. C: Validation of the results
of  quantitative  real-time  PCR  by
traditional PCR. Traditional PCR using
the series diluted cDNA of EAU retina
at 14 dpi and undiluted cDNA from the
CFA  control  was  performed,  and  the
relative  expression  of  the  selected
factors was compared with the results
from quantitative real-time PCR. In line
with  the  most  significant  5,202  fold
upregulation at EAU 14 dpi on MHC-II
expression by real-time PCR analysis
(Table 3), its relative expression was the
most abundant as compared to that of
other  individually  examined  factors,
e.g.,  IL-17,  IL-23p40,  and  IL-6,  by
traditional PCR measurement. A visible
PCR band on electrophoresis by using
as little as 1/16 dilution of the original
cDNA was observed in the series PCR
for the expression of MHC-II with the
lowest 22 PCR cycles compared to that
of other sets of relevant PCR data, e.g.,
IL-17  with  33  cycles.  Data  represent
three repeated experiments.
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1498immunochemistry with an IL-17 antibody (Figure 2A,C) in
the retina and vitreous cavity within eyes from both groups of
animals.  Characteristic  retinal  folding,  retina  and  vitreous
infiltrates with EAU were observed in Figure 2A.
To examine the kinetics of related T-cell responses during
the  course  of  EAU  systemically  and  locally,  the  relative
abundance of mRNA for multiple T-cell-related molecules
was measured by real-time PCR. Data shown (Table 1, Table
2, and Table 3) are from measurement of tissues collected
from  two  of  the  representative  EAU  animals  of  one
immunization and compared with that of the CFA controls at
14 dpi by the 2ΔCT method [22] (Figure 1B). This set of
experiments was repeated three times through three batches
of immunization in Lewis rats, and similar real-time PCR data
were  obtained  (data  not  shown).  Because  the  collected
draining lymph node, the spleen, and the retina are from the
same  two  animals  and  thus  systemically  connected,  we
assumed that the expression levels or ratios of multiple Th17-
or Treg-related factors among different tissues may be better
comparable and reflect the inter-related linkage involved in
the  system’s  biology.  Furthermore,  traditional  PCR
technology was also applied to verify some of the real-time
PCR data (Figure 1C).
Th17 contributed to the ocular inflammation at the effector
phase  of  EAU  in  which  Treg  was  also  actively  involved:
Expression levels of T-cell-related molecules were analyzed
by  quantitative  real-time  PCR  systemically  with  draining
lymph nodes and the spleen and locally with the whole retinas
from both EAU and CFA control rats at 7, 14, 21, 28, and 35
dpi. These molecules included the Th17 initiation cytokines
(IL-6 and TGF-β), the expansion cytokine IL-23, the Th17-
signature  cytokines  and  their  relevant  receptor  (IL-17,
IL17F, and IL-17RA as IL-17R), the Treg cell-surface markers
(CD4 and CD25), and other related cell-surface molecules,
such  as  CD8,  MHC-I,  and  MHC-II.  In  addition,  key
transcription  factors  for  Th17  and  Treg  cells  (RORγt  and
Foxp3) and chemokine receptors for both of the two T-cell
subsets (CCR6 and CXCR5) were also included (Table 1,
Table 2, and Table 3).
Our kinetic data revealed that Th17 cells were initiated
systemically within draining lymph nodes but not the spleen
(Table 1 and Table 2). As in the spleen, the expression of most
of those detected factors was not changed significantly with
absolute fold changes of less than 2.00, as compared to the
control (Table 2). Data from draining lymph nodes (Table 1)
indicated that increased expression of IL-6 and IL-17 was
observed at 7 and 14 dpi, both peaked at 7 dpi during the
observation,  with  7.67  and  42.62  fold  upregulation,
respectively, compared to the control. The relative expression
of IL-17F also peaked at 7 dpi, with 15.77 fold upregulation,
and remained elevated at 14 dpi with a 2.42 fold increase
before returning to levels of the control at later phases. On the
other  hand,  expression  of  IL-17R  remained  significantly
decreased throughout the course of the experiment (Table 1).
In  addition,  only  slightly  enhanced  expression  of  the
transcription factor RORγt and slightly reduced expression of
the chemokine receptor CCR6 at 7 and 14 dpi were observed
over the entire course of observations. The expression of most
other related factors, such as CD4, CD8, and MHC-I, did not
change significantly at the time recorded, with the exception
of  MHC-II,  which  was  elevated  at  14  dpi  by  2.48  fold
compared to the control (Table 1). These sets of data indicated
that, although Th17 cells might be induced and they produced
high amounts of signature cytokines, including IL-17 and
IL-17F, at the initiation phase of EAU in the peripheral tissue,
the draining lymph nodes may not be the target organ for these
cells to mediate significant inflammation. Moreover, relative
expression of the Treg cell “master regulator” Foxp3 within
the  periphery  was  significantly  downregulated  at  7  dpi,
whereas at 14 dpi the expression of the Treg-lineage-specific
chemokine receptor CXCR5 was upregulated by 2.72 fold
compared to the control (Table 1).
Data obtained from the retinas indicated that, with the
most severe ocular inflammation being observed at 14 dpi
with EAU rats (Figure 1 and Figure 2), it was accompanied
with  peaks  of  the  relative  expression  of  every  molecule
examined within the time range, albeit to varied extents (Table
3, data of 14 dpi). Notably, the temporal pattern expression of
RORγt, CCR6, and other Th17-related molecules suggested
the  progression  of  Th17  cells  from  secondary  lymphoid
organs to the retinas during the initiation and effector phases
of disease (data of 7 and 14 dpi, Table 1 and Table 3). In
addition, decreased expression of the subunit p40 of IL-23 was
observed at 7 dpi of both draining lymph nodes (Table 1) and
the  retinas  (Table  3),  while  significantly  unbalanced
expression was observed between IL-23p40 and IL-23p19,
with the p40 induced in excess over the other subunit at the
retinas for the time points after 14 dpi (Table 3). Moreover,
the relative expressions of CD4 and CD8 were increased to
36.13 fold versus 9.58 fold of the individual control, with the
level  of  CD4  expression  significantly  higher  than  that  of
CD8, in addition to the 5,202.54 fold upregulation of MHC-
II  and  8.63  fold  increase  of  MHC-I  expression  at  the
equivalent  time  point  (Table  3,  data  of  14  dpi).  These
quantitative PCR data showed that Th17 cells were at least
one subset of the major pathogenic effector T cells involved
in severe ocular inflammation. This was further supported by
data  obtained  from  retina  immunochemistry  with  IL-17
antibody,  which  showed  that  intensive  IL-17-positive
infiltrating immune cells were observed especially at 14 dpi
in both the retina and vitreous cavity within the eyes of EAU
(Figure 2A,C, arrowheads). In addition, the morphological
and regional features of the positive-staining cells resembled
cells of lymphoid origin (Figure 2C, arrowhead).
Retinal  expression  of  Treg-related  molecules  also
significantly  increased  at  14  dpi.  These  included  the
transcription  factor  Foxp3  (10.59  fold  upregulation),
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1499Figure  2.  IL-17  was  expressed  by  both  resident  neural  cells  and  infiltrating  lymphoid  cells  within  the  eyes  of  EAU  animals.
Immunohistochemistry with an IL-17-specific rabbit antirat antibody was employed to examine the intracellular staining on 7 (data not shown),
14, 21, 28, and 35 dpi of the retina and that of the CFA control at 14 dpi or vitreous cavity of the eye of EAU at 14 dpi. None-immune rabbit
IgG was used as the antibody isotypic control applied on the retina of the CFA control. A: IL-17 expression at the retinas. No disease and
normal retinal architecture was observed at both the isotype antibody control and CFA control. Disrupted retinal architecture and full-thickness
retinal damage with intensive infiltrating cells were observed at 14 dpi, but the normal retina structure was gradually restored after 21 dpi.
IL-17-positive staining was detected at the layer where retinal ganglion cells (RGC) and retinal astrocytes resided at the retina, with light
staining at the retina of the CFA control and strong staining at 14, 21, 28, and 35 dpi of retinas of EAU rats (arrows). The network of neural
processes also stained positively for IL-17. Closer observation on some of the positive-staining cells indicated that these cells morphologically
resembled astrocytes (EAU 28 dpi, insert with the arrow). Furthermore, a certain amount of the infiltrating cells at 14 dpi of the EAU group
also indicated positive staining (arrowhead). The size bar represents 50 μm (40×). B: GFAP+ retinal astrocytes and Tuj-1+RGC reside at the
RGC layer of the retina. GFAP (Green); Tuj-1 (red), and DAPI (blue). C: Selected IL-17 expression at the vitreous cavity within the eyes of
EAU 14 dpi. A significant amount of the infiltrating cells in the vitreous cavity within the eyes of EAU 14 dpi showed strong intracellular
staining of IL-17 (arrowhead). The morphology of positive-staining cells infiltrating the retinas resembled cells of lymphoid origins. Data
represent at least three repeated experiments. The size bar represents 50 μm (40×).
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1500chemokine  receptor  CXCR5  (8.08  fold  upregulation),  the
surface  molecule  CD25  (146.02  fold  upregulation),  and
related  molecules,  some  of  which  overlapped  with  Th17-
related molecules (i.e., TGF-β and CD4; Table 3, data of 14
dpi). These results indicated that at the peak of EAU the
infiltrating immune cells were highly heterogeneous, while
immune balance and regulation were operated by significant
induction of Treg cells.
Resident neural cells and infiltrating microglia are activated
during the course of EAU: To further observe the response of
resident retinal neural cells during the course of disease, glial
fibrillary  acidic  protein  (GFAP)-positive  astrocytes  and
neuron-specific class III β-tubulin (Tuj-1)-positive RGC were
analyzed  by  fluorescent  microscopy.  Increased  GFAP
expression represented activated astrocytes, Müller cells, and
gliosis of neurodegeneration [23]. In the CFA control (Figure
3A) and EAU 7 dpi (Figure 2B and Figure 3B) groups, there
was no detectable GFAP in Müller cells and the labeling only
occurred in astrocytes. At 14, 21, 28, and 35 dpi (Figure 3C-
F),  GFAP  was  detectable  throughout  the  Müller  cell
cytoplasm  and  GFAP+  astrocytes  became  wider  and
significantly pleomorphic with their processes enlarged. Such
morphological changes showed significant activation of the
retinal  astrocytes.  In  parallel,  Tuj-1-positive  staining
increased and spread from 7 dpi, became the most intensive
at 21 dpi, and was then slowly downregulated (Figure 4A,B).
To verify RGC loss or axonal regeneration during the course
of EAU, we measured the relative expression of thymocyte
differentiation  antigen  1  (Thy-1)  and  growth-associated
protein-43 (Gap-43) by real-time PCR. Thy-1 is a marker
specific for RGC, and reduced expression of Thy-1 at the
mRNA level was reported to be highly relevant to the state of
RGC [24]; whereas as a neuron-specific protein, Gap-43 is
considered a crucial component of the axon and presynaptic
terminal [25]. Data indicated that, although the expression
levels of these two factors were equivalent at each stage of
disease, the expression of both factors was increased to some
extent by 1.87 fold (Thy-1) and 2.12 fold (Gap-43) at 35 dpi,
compared  to  the  control  (Figure  4C).  Collectively,  this
expression pattern of Thy-1 and Gap43 at the later stage of
EAU (Figure 4C) was consistent with the sets of fluorescent
microscopy data in neural cells in which the increased again
expression of GFAP- and Tuj-1 staining was found at 35 dpi
(Figure 3, Figure 4A,B); and the set of real-time PCR data on
the expression of T-cell-related molecules at the same time
(Table 3).
To determine if infiltrating or resident microglia were
involved in the course of EAU, we also examined CD11b
expression in the retina. We found a significant number of
CD11b+ cells at 14 dpi (Figure 5) but not at other stages of
EAU  (data  not  shown).  This  showed  that,  as  infiltrating
immune cells, microglia might be mainly involved in the peak
of  disease,  especially  when  intraocular  inflammation  is
intensive.
Pattern expression of the overlapping molecules indicated
their role in promoting resolution of the monophasic EAU:
Although the previous results demonstrated Th17 cells as a
major pathogenic factor responsible for the peak of disease,
retinal expression of most T-cell-related factors did not return
to that of their respective control at a later phase of disease
(Table 3). Starting from 21 dpi, the stage of EAU was defined
as the resolution stage during which the retina underwent
significant clinical recovery (Figure 1A). A similar expression
pattern in which the expression was reduced from the peak of
EAU to 21 and 28 dpi but then increased again at 35 dpi was
observed for IL-17, IL-6, TGF-β, IL-23p40, RORγt, MHC-II,
MHC-I, and Foxp3. In addition, expression of IL-17R, CD4,
CCR6,  CXCR5,  and  CD25  was  significantly  increased  as
compared to each of the controls at this phase, although the
level of expression was far less than that of the respective
molecules at 14 dpi (Table 3). Significant correlation was
found between the kinetic expression of IL-17 and the set of
individual data of most of these molecules in EAU retinas
(p<0.05 or 0.01, Table 3). In contrast, most of the molecules
only slightly changed in the peripheral lymphoid organs of
EAU at the same period of time, with the exception of IL-17,
whose expression increased up to 3.21 fold at 28 dpi and
remained increased by 1.94 fold at 35 dpi compared to the
control (Table 1). This might specify functional properties of
these factors in the local environment. Based on these data we
hypothesized that these immune-based factors might also be
produced by resident neural cells and function as factors to
promote retinal structure reconstruction and function.
Immunohistochemistry with an IL-17-specific antibody
supported our hypothesis, at least to some extent. Consistently
high levels of IL-17 expression were observed in the retina of
EAU  where  RGC  and  astrocytes  resided  from  14  dpi
compared to that of the controls. Closer observation of IL-17-
positive staining cells demonstrated the intracellular staining
and  that  morphology  of  these  cells  resembled  astrocytes.
However, other than the location, we have no further evidence
to prove that the IL-17-positive staining cells were indeed
RGCs.  These  results  suggested  that  kinetic  expression  of
IL-17  by  resident  neural  cells  may  indicate  a  process  of
resolution in EAU.
DISCUSSION
The  present  study  indicated  how  well  organized  T-cell
activity, measured by relative expression of multiple T-cell-
related factors at the mRNA level, synchronized with the
initiation  of  the  autoimmune  inflammation  and  thereafter
resolution of a monophasic EAU with Lewis rats. The immune
balance was achieved several times, one at the peak of disease
(14 dpi) and another at the resolution phase (35 dpi) during
the  recorded  observation  period,  through  the  coordinated
expression of Th17- and that of Treg-associated molecules. In
addition, as these T-cell-related molecules are not functionally
exclusive to immune cells, the expression pattern of these
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1501factors  and  immunochemistry  with  an  IL-17  antibody
indicated that there may be intensive crosstalk between the
infiltrating immune cells and resident neural cells, which were
significantly activated during the course of disease.
Our data on kinetic expression of multiple T-cell-related
factors in vivo indicate novel findings that partial states of
differentiation or T-cell flexibility, in which components of
Th17 and Treg phenotypes were co-expressed, may dominate
effector/regulatory  or  even  memory  CD4  cell  populations
during  the  course  of  autoimmune  inflammation.  In  vitro
studies indicated that significant number of CD4 T cells co-
expressing  Foxp3  and  ROR-γt  were  found  in  human
Figure 3. Activation patterns of resident retinal astrocytes and Müller cells during EAU. The antibody against glial fibrillary acidic protein
(GFAP; green) was used to identify astrocytes and Müller cells; 2-(4-amidinophenyl)-6-indolecarbamidine dihydrochloride (DAPI; blue) was
applied to counterstain the cell nuclei. In the CFA control (A) and EAU 7 dpi group (B), there were no detectable GFAP in the endfeet of
Müller cells (ILM), and GFAP staining was limited within astrocytes (NFL). Panels C (14 dpi), D (21 dpi), E (28 dpi), and F (35 dpi) show
that GFAP became detectable throughout the Müller cell cytoplasm from INL to ONL (bidirectional arrows). In addition, positive staining
widened and enlarged in astrocytes (arrows), which turned pleomorphic (hypertrophy of the cell body and nucleus, elongation of cytoplasmic
processes, irregular in shape) and continuously activated from 14 to 35 dpi. Data represent at least three repeated experiments. OLM, outer
limiting membrane; ONL, outer nuclear layer; INL, inner nuclear layer; ILM, inner limiting membrane; NFL, nerve fiber layer. The size bar
represents 200 μm (10×).
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1502Figure 4. Status of the RGC during EAU. Tuj-1 staining (green) by an antibody against neuronal β3-tubulin in cell bodies and axons showed
microtubule stability of the neuronal cells. DAPI (blue) was applied to counterstain the cell nuclei. A: During the course of EAU, Tuj-1-
positive staining increased and spread at 7 dpi, appeared disrupted at the peak of inflammation at 14 dpi, and became the most intensive at 21
dpi with the restoration of normal retinal architecture. The staining was then downregulated at 28 dpi but became relatively stronger again at
35 dpi. The size bar represents 200 μm (10×). B: High magnification observation (40×) on the Tuj-1-positive staining showed that, while
microtubules of the neuronal axons were destabilized and disassembled when the disease progressed, they gradually restored their features at
later stages of EAU. Compared to the staining of the control and that at 28 dpi, distribution of Tuj-1-staining at 35 dpi indicated that the
neuronal activities underwent waves of adjustment at the later phase of disease. C: Relative expression of thymocyte differentiation antigen
1 (Thy-1) and growth-associated protein-43 (Gap-43) during EAU by real-time RT–PCR. Data represent at least three repeated experiments.
RPE, retinal pigment epithelium; ONL, outer nuclear layer; INL, inner nuclear layer; RGC, retina ganglion cells. The size bar represents 50
μm (40×).
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1503Figure 5. Infiltrating macrophages or microglia were involved in the peak of disease at 14 dpi. CD11b (green) was stained as the β-integrin
marker of microglia or mature macrophages. DAPI (blue) was applied to counterstain the cell nuclei. To determine the involvement of
infiltrating or resident microglia, CD11b expression was examined in the retina during the course of EAU. Detectable CD11b-positive staining
(green) was only observed at 14 dpi but not at other stages of disease (data not shown). The positive staining indicated that CD11b was a cell-
surface molecule (CD11b, middle column 40×). The size bar (left panels) represents 200 μm (10×) and the size bar (right panels) represents
50 μm (40×).
Molecular Vision 2011; 17:1493-1507 <http://www.molvis.org/molvis/v17/a168> © 2011 Molecular Vision
1504peripheral tissues; these cells produced IL-17 and powerfully
inhibited the proliferation of CD4 responder cells ex vivo
[19]. The existence of IFN-γ+IL-4+ cells under Th2 culture
conditions implies that partially differentiated Th1 cells retain
their capability to become IL-4-producing cells [26]. After
three  to  four  rounds  of  in  vitro  Th2  priming,  most  fully
differentiated  Th2  cells  failed  to  generate  IFN-γ,  which
correlates with the failure of T-bet (T box expressed in T cells)
induction  in  these  cells  [27].  These  demonstrate  that  the
plasticity of T cells may depend on their differentiation state.
However,  substantial  evidence  suggests  that  the  in  vivo
effector/regulatory  CD4  T  cells  may  have  undergone
pathways of differentiation that vary from those established
in  vitro  [28].  As  the  features  of  T-cell  heterogeneity  and
plasticity are highly inter-related, the complexity involved in
T-cell-mediated autoimmune inflammation in vivo cannot be
well understood by activities of only a few key molecules of
T cells. Our optimized real-time PCR measurement on parallel
activities of multiple interconnected molecules, related to two
subsets of T cells at the mRNA level, is designed adaptively,
and the data reflect a certain part of T-cell biology in vivo
during a period of time when an autoimmune inflammation
was initiated and resolved.
The same sets of our data further elucidate that immune
balance and regulation is well achieved by relevant activities
of pro-inflammatory Th17 cells and immunosuppressive Treg
at  certain  key  points  during  the  course  of  disease.  These
activities were reflected by coordinated expression of inter-
related signature cytokines, master regulator of transcriptional
factors, and key cell surface molecules that belong to either
of the two T-cell lineages, although some of the molecules
functionally overlapped. Overall, the dosage and timing of T-
cell activities are well correlated with disease progression and
resolution. However, other molecules that are key to Th1 and
Th2 subsets should also be tested for measurement on more
integrated  T-cell  activities  involved  in  autoimmune
inflammation in vivo. Such PCR measurements should also
be applied in recurrent EAU. Thus, the varied T-cell biology
between  monophasic  and  recurrent  autoimmune  disease
models may elucidate in detail the role of T-cell-mediated
immune responses in disease pathology and help to develop
treatment  strategies.  Nevertheless,  heterogeneity  and
plasticity of T cells may be far more complex. For example,
high levels of master regulator gene expression are usually
correlated with the phenotype of the proper Th subsets. Some
effector functions of T cells may not require these factors to
be highly expressed [29]. The functionality of the factor may
depend on the cell milieu or, more specifically, on the relative
amounts  of  other  vital  transcription  factors  in  a  kinetic
manner. Moreover, further measurements on key molecules
at the protein level and epigenetic regulation at the DNA level
are also necessary to help understand this complexity [30].
During  the  course  of  an  active  autoimmune
inflammation,  the  infiltrating  immune  cells  are  actively
interacted with the local neural tissues; thus these immune
cell-related molecules may not be exclusive to any cell type
or individual system [31] but function as mediators. In our
results, the most upregulated expression of MHC-II at the
EAU  retina  indicated  that  this  molecule  may  be  actively
involved in antigen presentation to CD4 T cells by resident
neural  tissue  during  the  course  of  EAU.  In  addition,  we
showed that IL-17 was also produced by retinal astrocytes or
RGCs,  especially  at  the  later  phase  of  EAU.  As  a  pro-
inflammatory  cytokine,  IL-17  was  also  shown  to  have
pleiotropic  and  environment-specific  protective  functions
[8,9]. An earlier structure study revealed significant structural
similarity between IL-17 family members and neurotrophins
[32]. To further support this notion, significant correlation
(p<0.05  or  0.01)  was  found  between  the  series  data  of
expression of IL-17 and that of IL-6,TGF-β,IL-23p40,CD4,
and MHC-II in EAU retinas. Interestingly, some of these
factors have also been shown to have potent functions, for
example, neurotrophins, such as IL-6 [33] and TGF-β [34].
Furthermore, co-culture with activated CD4 T cells resulted
in the destabilization of microtubules detected by the Tuj-1
antibody against β3-tubulin in neuronal axon [35]. From our
results, significant reorganization of β3-tubulin in RGCs at 35
dpi of retina of EAU animals closely correlated with increased
expression of those immune-based molecules at the same time
compared to individual features at 28 dpi and the controls.
Such parallel data strongly suggest that these immune-based
molecules influence neuronal activities and functions at the
local organ during the disease.
In conclusion, based on the organ-specific autoimmune
model of monophasic EAU, our data provide novel findings
regarding in vivo mechanisms of dynamic effector/regulatory
T-cell  subsets  on  immune  regulations  and  functional
interactions between the infiltrating immune cells and resident
neural  cells  mediated  by  T  cell-related  factors  during  the
course of disease.
ACKNOWLEDGMENTS
This study was supported by the National Natural Science
Foundation of China (NSFC 30772238), Young Researcher
Grant (060030) of Harbin Medical University, Harbin, China.
REFERENCES
1. Caspi  RR.  Immune  mechanisms  in  uveitis.  Springer  Semin
Immunopathol 1999; 21:113-24. [PMID: 10457585]
2. Amadi-Obi  A,  Yu  CR,  Liu  X,  Mahdi  RM,  Clarke  GL,
Nussenblatt RB, Gery I, Lee YS, Egwuagu CE. TH17 cells
contribute to uveitis and scleritis and are expanded by IL-2
and inhibited by IL-27/STAT1. Nat Med 2007; 13:711-8.
[PMID: 17496900]
3. Agarwal  RK,  Caspi  RR.  Rodent  models  of  experimental
autoimmune uveitis. Methods Mol Med 2004; 102:395-419.
[PMID: 15286397]
4. Luger  D,  Silver  PB,  Tang  J,  Cua  D,  Chen  Z,  Iwakura  Y,
Bowman EP, Sgambellone NM, Chan CC, Caspi RR. Either
Molecular Vision 2011; 17:1493-1507 <http://www.molvis.org/molvis/v17/a168> © 2011 Molecular Vision
1505a Th17 or a Th1 effector response can drive autoimmunity:
conditions  of  disease  induction  affect  dominant  effector
category. J Exp Med 2008; 205:799-810. [PMID: 18391061]
5. O'Connor W Jr, Zenewicz LA, Flavell RA. The dual nature of
T(H)17 cells: shifting the focus to function. Nat Immunol
2010; 11:471-6. [PMID: 20485275]
6. Klegeris A, Walker DG, McGeer PL. Regulation of glutamate
in  cultures  of  human  monocytic  THP-1  and  astrocytoma
U-373 MG cells. J Neuroimmunol 1997; 78:152-61. [PMID:
9307240]
7. Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC. Cytokine
effects  on  glutamate  uptake  by  human  astrocytes.
Neuroimmunomodulation 2000; 7:153-9. [PMID: 10754403]
8. O'Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S,
Iwakura Y, Kolls JK, Flavell RA. A protective function for
interleukin 17A in T cell-mediated intestinal inflammation.
Nat Immunol 2009; 10:603-9. [PMID: 19448631]
9. Ogawa  A,  Andoh  A,  Araki  Y,  Bamba  T,  Fujiyama  Y.
Neutralization of interleukin-17 aggravates dextran sulfate
sodium-induced  colitis  in  mice.  Clin  Immunol  2004;
110:55-62. [PMID: 14962796]
10. Schwartz M, Butovsky O, Kipnis J. Does inflammation in an
autoimmune  disease  differ  from  inflammation  in
neurodegenerative  diseases?  Possible  implications  for
therapy. J Neuroimmune Pharmacol 2006; 1:4-10. [PMID:
18040786]
11. Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN, Qin H.
IL-17  enhancement  of  the  IL-6  signaling  cascade  in
astrocytes.  J  Immunol  2010;  184:4898-906.  [PMID:
20351184]
12. Liu  Y,  Teige  I,  Birnir  B,  Issazadeh-Navikas  S.  Neuron-
mediated  generation  of  regulatory  T  cells  from
encephalitogenic T cells suppresses EAE. Nat Med 2006;
12:518-25. [PMID: 16633347]
13. Trajkovic  V,  Vuckovic  O,  Stosic-Grujicic  S,  Miljkovic  D,
Popadic  D,  Markovic  M,  Bumbasirevic  V,  Backovic  A,
Cvetkovic I, Harhaji L, Ramic Z, Mostarica SM. Astrocyte-
induced regulatory T cells mitigate CNS autoimmunity. Glia
2004; 47:168-79. [PMID: 15185395]
14. Mizrahi T, Hauben E, Schwartz M. The tissue-specific self-
pathogen is the protective self-antigen: the case of uveitis. J
Immunol 2002; 169:5971-7. [PMID: 12421983]
15. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger
B. TGFbeta in the context of an inflammatory cytokine milieu
supports de novo differentiation of IL-17-producing T cells.
Immunity 2006; 24:179-89. [PMID: 16473830]
16. Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T
cells induce CD4+CD25-Foxp3- T cells or are self-induced
to become Th17 cells in the absence of exogenous TGF-beta.
J Immunol 2007; 178:6725-9. [PMID: 17513718]
17. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu
BP, Shah B, Chang SH, Schluns KS, Watowich SS, Feng XH,
Jetten AM, Dong C. Molecular antagonism and plasticity of
regulatory  and  inflammatory  T  cell  programs.  Immunity
2008; 29:44-56. [PMID: 18585065]
18. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD,
Shen  Y,  Du  J,  Rubtsov  YP,  Rudensky  AY,  Ziegler  SF,
Littman DR. TGF-beta-induced Foxp3 inhibits T(H)17 cell
differentiation  by  antagonizing  RORgammat  function.
Nature 2008; 453:236-40. [PMID: 18368049]
19. Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY,
Li Y, Wang HY, Wang RF. Toll-like receptor 8-mediated
reversal of CD4+ regulatory T cell function. Science 2005;
309:1380-4. [PMID: 16123302]
20. Leung S, Liu X, Fang L, Chen X, Guo T, Zhang J. The cytokine
milieu in the interplay of pathogenic Th1/Th17 cells and
regulatory T cells in autoimmune disease. Cell Mol Immunol
2010; 7:182-9. [PMID: 20383174]
21. Mai J, Wang H, Yang XF. Th 17 cells interplay with Foxp3+
Tregs in regulation of inflammation and autoimmunity. Front
Biosci 2010; 15:986-1006. [PMID: 20515737]
22. Vandesompele J, De PK, Pattyn F, Poppe B, Van RN, De PA,
Speleman F. Accurate normalization of real-time quantitative
RT-PCR data by geometric averaging of multiple internal
control  genes.  Genome  Biol  2002;  3:RESEARCH0034.
[PMID: 12184808]
23. Lam D, Jim J, To E, Rasmussen C, Kaufman PL, Matsubara J.
Astrocyte and microglial activation in the lateral geniculate
nucleus and visual cortex of glaucomatous and optic nerve
transected  primates.  Mol  Vis  2009;  15:2217-29.  [PMID:
19898640]
24. Nash MS, Osborne NN. Assessment of Thy-1 mRNA levels as
an index of retinal ganglion cell damage. Invest Ophthalmol
Vis Sci 1999; 40:1293-8. [PMID: 10235569]
25. Benowitz LI, Routtenberg A. GAP-43: an intrinsic determinant
of  neuronal  development  and  plasticity.  Trends  Neurosci
1997; 20:84-91. [PMID: 9023877]
26. Zhu J, Min B, Hu-Li J, Watson CJ, Grinberg A, Wang Q, Killeen
N, Urban JF Jr, Guo L, Paul WE. Conditional deletion of
Gata3 shows its essential function in T(H)1-T(H)2 responses.
Nat Immunol 2004; 5:1157-65. [PMID: 15475959]
27. Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells.
Cell Res 2010; 20:4-12. [PMID: 20010916]
28. Murphy KM, Stockinger B. Effector T cell plasticity: flexibility
in the face of changing circumstances. Nat Immunol 2010;
11:674-80. [PMID: 20644573]
29. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T
cell populations (*). Annu Rev Immunol 2010; 28:445-89.
[PMID: 20192806]
30. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, Cui K, Kanno
Y, Roh TY, Watford WT, Schones DE, Peng W, Sun HW,
Paul WE, O'Shea JJ, Zhao K. Global mapping of H3K4me3
and H3K27me3 reveals specificity and plasticity in lineage
fate determination of differentiating CD4+ T cells. Immunity
2009; 30:155-67. [PMID: 19144320]
31. Kerschensteiner  M,  Meinl  E,  Hohlfeld  R.  Neuro-immune
crosstalk  in  CNS  diseases.  Neuroscience  2009;
158:1122-32. [PMID: 18848864]
32. Hymowitz SG, Filvaroff EH, Yin JP, Lee J, Cai L, Risser P,
Maruoka M, Mao W, Foster J, Kelley RF, Pan G, Gurney AL,
de Vos AM, Starovasnik MA. IL-17s adopt a cystine knot
fold: structure and activity of a novel cytokine, IL-17F, and
implications  for  receptor  binding.  EMBO  J  2001;
20:5332-41. [PMID: 11574464]
33. de Araujo EG, da Silva GM, Dos Santos AA. Neuronal cell
survival: the role of interleukins. Ann N Y Acad Sci 2009;
1153:57-64. [PMID: 19236328]
34. Roussa E. von Bohlen und HO, Krieglstein K. TGF-beta in
dopamine  neuron  development,  maintenance  and
Molecular Vision 2011; 17:1493-1507 <http://www.molvis.org/molvis/v17/a168> © 2011 Molecular Vision
1506neuroprotection.  Adv  Exp  Med  Biol  2009;  651:81-90.
[PMID: 19731553]
35. Dittel BN. CD4 T cells: Balancing the coming and going of
autoimmune-mediated  inflammation  in  the  CNS.  Brain
Behav Immun 2008; 22:421-30. [PMID: 18207698]
Molecular Vision 2011; 17:1493-1507 <http://www.molvis.org/molvis/v17/a168> © 2011 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 2 June 2011. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1507